Design, synthesis, and biological evaluation of dithiocarbamate derivatives as SARS-CoV-2 M pro inhibitors

被引：0
|
作者：
Peng, Jin-Qi [1 ]
Xiao, Ya-Qi [1 ]
Long, Jiao [1 ]
Zhang, Shuang-Shuang [1 ]
Zhu, Yuan-Yuan [2 ]
Gu, Shuang-Xi [1 ]
机构：
[1] Wuhan Inst Technol, Sch Chem Engn & Pharm, Hubei Key Lab Novel Reactor & Green Chem Technol, Wuhan 430205, Peoples R China
[2] Wuhan Inst Technol, Sch Chem & Environm Engn, Wuhan 430205, Peoples R China
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2024年 / 114卷
关键词：
SARS-CoV-2; Main protease; Dithiocarbamates derivatives; Drug design;
D O I：
10.1016/j.bmcl.2024.130011
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
SARS-CoV-2 continues to mutate, spread, and impact public health and daily life. The main protease (Mpro) is essential for the replication and maturation of SARS-CoV-2, making it an ideal target for anti-coronaviral drug discovery and development due to its high conservation and lack of homologous proteases in humans. Herein, we designed and synthesized a series of dithiocarbamate derivatives as potent SARS-CoV-2 M pro inhibitors. Notably, compound L2 exhibited an IC50 value of 9.1 +/- 2.0 nM against SARS-CoV-2 M pro , underscoring its potential as a promising candidate for anti-coronaviral therapy and justifying further research and development.
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Repurposing and computational design of PARP inhibitors as SARS-CoV-2 inhibitors
    Rampogu, Shailima
    Jung, Tae Sung
    Ha, Min Woo
    Lee, Keun Woo
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [32] Repurposing and computational design of PARP inhibitors as SARS-CoV-2 inhibitors
    Shailima Rampogu
    Tae Sung Jung
    Min Woo Ha
    Keun Woo Lee
    Scientific Reports, 13
  • [33] Discovery of M Protease Inhibitors Encoded by SARS-CoV-2
    Hung, Hui-Chen
    Ke, Yi-Yu
    Huang, Sheng Yu
    Huang, Peng-Nien
    Kung, Yu-An
    Chang, Teng-Yuan
    Yen, Kuei-Jung
    Peng, Tzu-Ting
    Chang, Shao-En
    Huang, Chin-Ting
    Tsai, Ya-Ru
    Wu, Szu-Huei
    Lee, Shiow-Ju
    Lin, Jiunn-Horng
    Liu, Bing-Sin
    Sung, Wang-Chou
    Shih, Shin-Ru
    Chen, Chiung-Tong
    Hsu, John Tsu-An
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (09)
  • [34] Design, synthesis, and biological evaluation of indole-2-carboxamides as SARS CoV-2 main protease inhibitors
    Gomaa, Hesham A. M.
    Shaker, Mohamed E.
    Alzarea, Sami I.
    Alsahli, Tariq G.
    Hendawy, Omnia
    Mohammed, Yasser Khamis
    Younes, M. Khaled
    Rahman, Fatema El-Zahraa S. Abdel
    Mohamed, Fatma A. M.
    Raoof, Gehan Fawzy Abdel
    Mahmoud, Mohamed A.
    Gouda, Ahmed M.
    Bakr, Adel G.
    Youssif, Bahaa G. M.
    TETRAHEDRON, 2023, 146
  • [35] Design, synthesis, and biological activity evaluation of dihydromyricetin derivatives against SARS-CoV-2-Omicron virus
    Wu, Cong
    Jiang, Qi
    Zhong, Hui
    Zhou, Xudong
    Liu, Leping
    Pan, Tong
    Liu, Chao
    Wang, Wei
    Sheng, Wenbing
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2024, 39 (01)
  • [36] Design and Evaluation of Peptide Inhibitors Targeting the Dimerization of SARS-CoV-2 Main Protease
    Yang, Yi
    Zhao, Zhiyi
    Li, Xiaoying
    Chen, Yian
    Liu, Lu
    Zhang, Shao-Lin
    Yang, Aimin
    CHEMBIOCHEM, 2025, 26 (01)
  • [37] Design and Evaluation of Bispidine-Based SARS-CoV-2 Main Protease Inhibitors
    Shcherbakov, Dmitriy
    Baev, Dmitriy
    Kalinin, Mikhail
    Dalinger, Alexander
    Chirkova, Varvara
    Belenkaya, Svetlana
    Khvostov, Aleksei
    Krut'ko, Dmitry
    Medved'ko, Aleksei
    Volosnikova, Ekaterina
    Sharlaeva, Elena
    Shanshin, Daniil
    Tolstikova, Tatyana
    Yarovaya, Olga
    Maksyutov, Rinat
    Salakhutdinov, Nariman
    Vatsadze, Sergey
    ACS MEDICINAL CHEMISTRY LETTERS, 2022, 13 (01): : 140 - 147
  • [38] Insights into targeting SARS-CoV-2: design, synthesis, in silico studies and antiviral evaluation of new dimethylxanthine derivatives
    Mohamed, Abdalla R.
    Mostafa, Ahmed
    El Hassab, Mahmoud A.
    Hedeab, Gomaa M.
    Mahmoud, Sara H.
    George, Riham F.
    Georgey, Hanan H.
    Abdel Gawad, Nagwa M.
    El-Ashrey, Mohamed K.
    RSC MEDICINAL CHEMISTRY, 2023, 14 (05): : 899 - 920
  • [39] MOLECULAR MODELLING AND THEORETICAL DESIGN OF NOVEL NIRMATRELVIR DERIVATIVES AS SARS-COV-2 ENTRY INHIBITORS
    Ezzat, Mohammed Oday
    Abd Razik, Basma M.
    Shihab, Wurood A.
    NEW MATERIALS COMPOUNDS AND APPLICATIONS, 2024, 8 (02):
  • [40] Computational Design of Miniproteins as SARS-CoV-2 Therapeutic Inhibitors
    Jawad, Bahaa
    Adhikari, Puja
    Cheng, Kun
    Podgornik, Rudolf
    Ching, Wai-Yim
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (02)
12345